PANCREATINA FORTE MYLAN 40000 400mg gastro-resistant capsules medication leaflet

A09AA02 pancreatin • Alimentary tract and metabolism | Digestives, incl. enzymes | Enzyme preparations

Pancreatin is a mixture of digestive enzymes used to aid in the digestion of food when the pancreas does not produce enough enzymes. These enzymes include amylase (for carbohydrate digestion), lipase (for fat digestion), and protease (for protein digestion). Pancreatin is indicated for the treatment of exocrine pancreatic insufficiency associated with conditions such as cystic fibrosis, chronic pancreatitis, pancreatic cancer, or after pancreatic surgery.

Pancreatin is taken orally, usually in the form of capsules or tablets, during or immediately after meals to support food digestion. The dosage is adjusted based on the severity of enzyme deficiency and the patient's diet.

Side effects are rare but may include nausea, diarrhea, constipation, abdominal pain, or allergic reactions. Long-term use of high doses may increase the risk of hyperuricemia (elevated uric acid levels). It is important to use pancreatin as directed by a healthcare provider, and patients should avoid chewing the capsules to prevent irritation of the oral mucosa.

General data about PANCREATINA FORTE MYLAN 40000 400mg

Substance: pancreatin

Date of last drug list: 01-01-2019

Commercial code: W63526002

Concentration: 400mg

Pharmaceutical form: gastro-resistant capsules

Quantity: 50

Product type: original

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: ABBOTT LABORATORIES GMBH - GERMANIA

Holder: MYLAN HEALTHCARE GMBH - GERMANIA

Number: 4974/2012/02

Shelf life: 2 years

Concentrations available for pancreatin

125mg, 150mg, 153.5mg, 200mg, 250mg, 275mg, 300mg, 325mg, 356.100mg, 400mg, 420mg, 90mg